Literature DB >> 21331392

Folate receptor targeted, carboxymethyl chitosan functionalized iron oxide nanoparticles: a novel ultradispersed nanoconjugates for bimodal imaging.

Dipsikha Bhattacharya1, Manasmita Das, Debashis Mishra, Indranil Banerjee, Sumanta K Sahu, Tapas K Maiti, Panchanan Pramanik.   

Abstract

This article delineates the design and synthesis of a novel, bio-functionalized, magneto-fluorescent multifunctional nanoparticles suitable for cancer-specific targeting, detection and imaging. Biocompatible, hydrophilic, magneto-fluorescent nanoparticles with surface-pendant amine, carboxyl and aldehyde groups were designed using o-carboxymethyl chitosan (OCMC). The free amine groups of OCMC stabilized magnetite nanoparticles on the surface allow for the covalent attachment of a fluorescent dye such as rhodamine isothiocyanate (RITC) with the aim to develop a magneto-fluorescent nanoprobe for optical imaging. In order to impart specific cancer cell targeting properties, folic acid and its aminated derivative was conjugated onto these magneto-fluorescent nanoparticles using different pendant groups (-NH(2), -COOH, -CHO). These newly synthesized iron-oxide folate nanoconjugates (FA-RITC-OCMC-SPIONs) showed excellent dispersibility, biocompatibility and good hydrodynamic sizes under physiological conditions which were extensively studied by a variety of complementary techniques. The cellular internalization efficacy of these folate-targeted and its non-targeted counterparts were studied using a folate-overexpressed (HeLa) and a normal (L929 fibroblast) cells by fluorescence microscopy and magnetically activated cell sorting (MACS). Cell-uptake behaviors of nanoparticles clearly demonstrate that cancer cells over-expressing the human folate receptor internalized a higher level of these nanoparticle-folate conjugates than normal cells. These folate targeted nanoparticles possess specific magnetic properties in the presence of an external magnetic field and the potential of these nanoconjugates as T(2)-weighted negative contrast MR imaging agent were evaluated in folate-overexpressed HeLa and normal L929 fibroblast cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21331392     DOI: 10.1039/c0nr00821d

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  11 in total

Review 1.  Recent progress on magnetic iron oxide nanoparticles: synthesis, surface functional strategies and biomedical applications.

Authors:  Wei Wu; Zhaohui Wu; Taekyung Yu; Changzhong Jiang; Woo-Sik Kim
Journal:  Sci Technol Adv Mater       Date:  2015-04-28       Impact factor: 8.090

2.  Revisiting the value of competition assays in folate receptor-mediated drug delivery.

Authors:  Steven K Jones; Anwesha Sarkar; Daniel P Feldmann; Peter Hoffmann; Olivia M Merkel
Journal:  Biomaterials       Date:  2017-05-22       Impact factor: 12.479

3.  Toxicological Aspects of Iron Oxide Nanoparticles.

Authors:  Natalia Fernández-Bertólez; Carla Costa; Fátima Brandão; João Paulo Teixeira; Eduardo Pásaro; Vanessa Valdiglesias; Blanca Laffon
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

4.  Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.

Authors:  Linhua Zhang; Dunwan Zhu; Xia Dong; Hongfan Sun; Cunxian Song; Chun Wang; Deling Kong
Journal:  Int J Nanomedicine       Date:  2015-03-16

5.  High molecular weight chitosan derivative polymeric micelles encapsulating superparamagnetic iron oxide for tumor-targeted magnetic resonance imaging.

Authors:  Yunbin Xiao; Zuan Tao Lin; Yanmei Chen; He Wang; Ya Li Deng; D Elizabeth Le; Jianguo Bin; Meiyu Li; Yulin Liao; Yili Liu; Gangbiao Jiang; Jianping Bin
Journal:  Int J Nanomedicine       Date:  2015-02-05

6.  Novel ZnO hollow-nanocarriers containing paclitaxel targeting folate-receptors in a malignant pH-microenvironment for effective monitoring and promoting breast tumor regression.

Authors:  Nagaprasad Puvvada; Shashi Rajput; B N Prashanth Kumar; Siddik Sarkar; Suraj Konar; Keith R Brunt; Raj R Rao; Abhijit Mazumdar; Swadesh K Das; Ranadhir Basu; Paul B Fisher; Mahitosh Mandal; Amita Pathak
Journal:  Sci Rep       Date:  2015-07-06       Impact factor: 4.379

7.  Folic acid-conjugated amphiphilic alternating copolymer as a new active tumor targeting drug delivery platform.

Authors:  Xia Li; Myron R Szewczuk; Cecile Malardier-Jugroot
Journal:  Drug Des Devel Ther       Date:  2016-12-15       Impact factor: 4.162

8.  Heparin and carboxymethylchitosan metal nanoparticles: an evaluation of their cytotoxicity.

Authors:  Adriana Bava; Francesca Cappellini; Elisa Pedretti; Federica Rossi; Enrico Caruso; Elena Vismara; Maurizio Chiriva-Internati; Giovanni Bernardini; Rosalba Gornati
Journal:  Biomed Res Int       Date:  2013-02-18       Impact factor: 3.411

9.  Carboxymethyl chitosan-folic acid-conjugated Fe3O4@SiO2 as a safe and targeting antitumor nanovehicle in vitro.

Authors:  Hongmei Li; Zhen Li; Jin Zhao; Baoqiang Tang; Yanhong Chen; Yikun Hu; Zhengda He; Yue Wang
Journal:  Nanoscale Res Lett       Date:  2014-03-25       Impact factor: 4.703

10.  Synthesis and characterization of oil-chitosan composite spheres.

Authors:  Keng-Shiang Huang; Chih-Yu Wang; Chih-Hui Yang; Alexandru Mihai Grumezescu; Yung-Sheng Lin; Chao-Pin Kung; I-Yin Lin; Yi-Ching Chang; Wei-Jie Weng; Wei-Ting Wang
Journal:  Molecules       Date:  2013-05-16       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.